NEWTOWN, Pa., June 4, 2025 /PRNewswire/ --
Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Semler Scientific, Inc. ("Semler") (NASDAQ: SMLR), resulting from allegations of providing potentially misleading business information to the investing public.
If you have non-public information that could assist in the Semler investigation, or if you are a Semler investor who suffered a loss and would like to learn more, you can provide your information HERE.
You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at [email protected].
THE COMPANY:
Semler Scientific is a healthcare technology company specializing in the development and marketing of products that aid in the early detection and management of chronic diseases, most notably through its flagship vascular testing device, QuantaFlo.
THE ALLEGED WRONGDOING:
On February 28, 2025, Semler filed its 2024 annual report with the SEC, disclosing that the Department of Justice was considering a False Claims Act complaint regarding insurance reimbursement claims related to the company's QuantaFlo testing device. On this news, Semler's stock fell $4.03 per share, or 9.4%, to close at $38.89 per share on March 3, 2025.
ABOUT EDELSON LECHTZIN LLP:
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft, data security, and consumer fraud.
For more information, please contact:
Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: [email protected]
Email: [email protected]
Web: www.edelson-law.com
This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
SOURCE Edelson Lechtzin LLP
